Timely End-of-Life Communication to Parents of Children With Brain Tumors
NCT ID: NCT01170000
Last Updated: 2011-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
6 participants
OBSERVATIONAL
2009-09-30
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systematic Light Exposure in Pediatric Brain Tumor Survivors
NCT05340881
Palliative Care and Symptom Management for the Pediatric Oncology Patient
NCT00675467
Revealing Information Genuinely & Honestly Across Time: Pediatric Oncology Stakeholder Preferences and Recommendations for Prognostic Communication
NCT05116566
Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
NCT02846038
Prospective Home-Based Palliative Care and Hospice Study
NCT06362239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Pediatric oncology physicians and nurses found PC/EOL care communication training strategies and content as helpful and useful. During Phase II of our study, our PC/EOL care communication intervention is planned to be implemented and evaluated with 24 enrolled parents. If effective, this intervention will facilitate integration of quality PC care practices into the care of children with brain tumors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older;
* the primary decision makers (i.e., single parent or couple-dyad) for their child (birth to 18 years of age);
* the biological parents, step-parents, or legal guardians (e.g., adoptive parent);
* single or married;
* informed that their child is diagnosed with a brain tumor with a poor prognosis as determined by the primary neuro-oncologist (e.g., glioblastoma multiforme, PNET, WHO grade 3/4 brain tumor, or metastatic medulloblastoma); \[3, 33, 38, 41, 42, 175\]
* able to read, speak, and understand English.
* Our rationale for these criteria is to include: (a) parents of children who are at high risk of not receiving timely PC/EOL and b) parents who are likely to be mature enough to make difficult decisions on their own. In addition, we recognize the importance of providing sensitive PC/EOL communication to all parents; however, it is beyond the scope of the R21 mechanism to develop scripts in other languages.
Exclusion Criteria
* the child's brain tumor has a good prognosis (e.g., a non-metastatic medulloblastoma);
* the child has been treated previously for another type of cancer;
* the parents have neurological and/or cognitive impairments, as reported by the site MD/RN team, preventing them from understanding the treatment options and completing the questionnaires;
* either parent in a decision-making couple (i.e., dyad) declines consent.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Nursing Research (NINR)
NIH
The Foundation for Barnes-Jewish Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barnes-Jewish Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Verna Ferguson, PhD
Role: PRINCIPAL_INVESTIGATOR
Barnes-Jewish Hospital
Joan Haase, PhD
Role: PRINCIPAL_INVESTIGATOR
Indiana University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Riley Children's Hospital
Indianapolis, Indiana, United States
Indiana University School of Nursing
Indianapolis, Indiana, United States
SSM Cardinal Glennon Children's Hospital
St Louis, Missouri, United States
Barnes-Jewish Hospital
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Joan Haase, PhD
Role: primary
Joan Haase, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-0763 BJH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.